Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Paul F. M. Kuks"'
Autor:
Joanna E. Klopotowska, Paul F. M. Kuks, Peter C. Wierenga, Clementine C. M. Stuijt, Lambertus Arisz, Marcel G. W. Dijkgraaf, Nicolette de Keizer, Susanne M. Smorenburg, Sophia E. de Rooij, on behalf of the WINGS Study Group
Publikováno v:
BMC Geriatrics, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background The effectiveness of interventions to improve medication safety in older inpatients is unclear, given a paucity of properly designed intervention studies applying clinically relevant endpoints such as hospital-acquired preventable
Externí odkaz:
https://doaj.org/article/00916a439f2c4ef39f0632c7cea4d9ed
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 165
Gurwitz and colleagues showed that a complex intervention, aimed at a reduction of drug-related adverse events and medication errors immediately after hospital discharge, did not result in a significant outcome difference between the intervention and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::606a90e2bda61ab9a056354cc90379c8
https://pubmed.ncbi.nlm.nih.gov/35138704
https://pubmed.ncbi.nlm.nih.gov/35138704
Autor:
Monica de Boer, Maya A Ramrattan, Eveline B Boeker, Paul F M Kuks, Marja A Boermeester, Loraine Lie-A-Huen
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101573 (2014)
BACKGROUND: Surgical patients are at risk for preventable adverse drug events (ADEs) during hospitalization. Usually, preventable ADEs are measured as an outcome parameter of quality of pharmaceutical care. However, process measures such as QIs are m
Externí odkaz:
https://doaj.org/article/6709860a89fa44ad912271bc9a4a163e
Autor:
Matthijs van Luin, Paul F M Kuks, Diari Faraj, Clemens Richter, André J. A. M. van der Ven, David M. Burger, Ferdinand W. N. M. Wit, Frank P. Kroon, L. B. S. Gelinck, Marchina E. van der Ende, Mirjam Visser, Ron H.N. van Schaik
Publikováno v:
AIDS (London, England), 24(8), 1223-1226. Lippincott Williams and Wilkins
Aids, 24, 1223-6
AIDS, 24(8), 1223-1226
AIDS, 24(8), 1223-1226. Lippincott Williams & Wilkins
Aids, 24, 8, pp. 1223-6
Aids, 24, 1223-6
AIDS, 24(8), 1223-1226
AIDS, 24(8), 1223-1226. Lippincott Williams & Wilkins
Aids, 24, 8, pp. 1223-6
Contains fulltext : 87324.pdf (Publisher’s version ) (Closed access) HIV-infected travellers frequently use atovaquone/proguanil as malaria prophylaxis. We compared atovaquone/proguanil pharmacokinetics between healthy volunteers and HIV-infected p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8697dfe643c316beed65ebaafcae1d68
https://pure.eur.nl/en/publications/3a349a4d-c17c-4395-8bfa-24ef6a94fabd
https://pure.eur.nl/en/publications/3a349a4d-c17c-4395-8bfa-24ef6a94fabd
Autor:
Leon Aarts, Klaas P. Zuideveld, Joost DeJongh, Paul F. M. Kuks, Meindert Danhof, Catherijne A. J. Knibbe
Publikováno v:
Clinical Pharmacology & Therapeutics. 72:670-684
Objectives A population pharmacokinetic and pharmacodynamic model of propofol for long-term sedation in critically ill patients is described, because limited information is available in these patients. In the models the influence of time-independent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1407ef5918e40b041c07e4d3c1b9f37
https://doi.org/10.1067/mcp.2002.129500
https://doi.org/10.1067/mcp.2002.129500
Autor:
Meindert Danhof, Gitte Melenhorst-de Jong, Hans Van Vught, Catherijne A. J. Knibbe, Maaike Mestrom, Allart F. A. Reijnvaan, Klaas P. Zuideveld, Carin M. A. Rademaker, Paul F. M. Kuks
Publikováno v:
British Journal of Clinical Pharmacology. 54:415-422
Aims This paper describes the pharmacokinetics and effects of propofol in short-term sedated paediatric patients. Methods Six mechanically ventilated children aged 1–5 years received a 6 h continuous infusion of propofol 6% at the rate of 2 or 3 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5a8ca832abca5bed3d2f675806d8c59
https://doi.org/10.1046/j.1365-2125.2002.01652.x
https://doi.org/10.1046/j.1365-2125.2002.01652.x
Autor:
Paul F. M. Kuks, Meindert Danhof, Rogier Lange, Catherijne A. J. Knibbe, Henk-Jan Voortman, Leon P. Aarts, Han J. Langemeijer
Publikováno v:
British Journal of Clinical Pharmacology. 47:653-660
Aims In order to avoid the potential for elevated serum lipid levels as a consequence of long term sedation with propofol, a formulation of propofol 6% in Lipofundin® MCT/LCT 10% (Propofol 6% SAZN) has been developed. The pharmacokinetics, induction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3c054869c1ab118d036745322a84291
https://doi.org/10.1046/j.1365-2125.1999.00942.x
https://doi.org/10.1046/j.1365-2125.1999.00942.x
Autor:
Eugene H. Cox, Meindert Danhof, E Tukker, Victorine S. Koster, Catherijne A. J. Knibbe, Han J. M. Langemeijer, M. W. E. Langemeijer, Loraine Lie-A-Huen, Rogier Lange, Paul F. M. Kuks
Publikováno v:
Pharmaceutical Research. 15:442-448
Purpose. The influence of different intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol was investigated using the effect on the EEG (11.5-30 Hz) as pharmacodynamic endpoint.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd649474a88323d98d7893b243ba4951
https://doi.org/10.1023/a:1011980432646
https://doi.org/10.1023/a:1011980432646
Autor:
Joanna E Klopotowska, Peter C Wierenga, Clementine C M Stuijt, Lambertus Arisz, Marcel G W Dijkgraaf, Paul F M Kuks, Henk Asscheman, Sophia E de Rooij, Loraine Lie-A-Huen, Susanne M Smorenburg, WINGS Study Group
Publikováno v:
PLoS ONE, 8(8). Public Library of Science
PLoS ONE, Vol 8, Iss 8, p e71045 (2013)
PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e71045 (2013)
PLoS ONE
BackgroundOlder patients are at high risk for experiencing Adverse Drug Events (ADEs) during hospitalization. To be able to reduce ADEs in these vulnerable patients, hospitals first need to measure the occurrence of ADEs, especially those that are pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039998035fa53ebdbd68a364c611a2de
https://pure.amc.nl/en/publications/adverse-drug-events-in-older-hospitalized-patients-results-and-reliability-of-a-comprehensive-and-structured-identification-strategy(be3b0dcf-b4d5-4107-a23c-1063dfe1b865).html
https://pure.amc.nl/en/publications/adverse-drug-events-in-older-hospitalized-patients-results-and-reliability-of-a-comprehensive-and-structured-identification-strategy(be3b0dcf-b4d5-4107-a23c-1063dfe1b865).html
Publikováno v:
Current Opinion in Hiv and Aids, 3, 266-71
Current Opinion in Hiv and Aids, 3, 3, pp. 266-71
Current Opinion in Hiv and Aids, 3, 3, pp. 266-71
Therapeutic drug monitoring is frequently used in several European countries, and international guidelines recommend it in selected cases. We discuss the main arguments for and against therapeutic drug monitoring in HIV infection.Accumulating evidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccaba5cc4b0efa48494302666492537c
https://pubmed.ncbi.nlm.nih.gov/19372977
https://pubmed.ncbi.nlm.nih.gov/19372977